Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1976-3-18
|
pubmed:abstractText |
Blood lymphocytes from twenty-three untreated patients with Hodgkin's disease and twelve healthy controls were studied for their ability to lyse tissue culture cells (Chang cells) labelled with [51Cr]chromate. Lysis induced by patients' lymphocytes in the presence of PHA or rabbit IgG antibodies to Chang cells (ACS) was impaired in some, and higher than normal in others. ACS-induced lysis showed some corlation with the content of lymphocytes carrying receptors for human complement (CRL) in the effectory population. No correlation with immunoglobulin-bearing cells was noted. PHA-induced cytoxicity did not correlate with lymphocyte subpopulations. The observations are consistent with the assumption that effector cells of antibody-induced lymphocyte-mediated cytotoxicity (K cells) may be present among CRL. The K-cell activity and PHA cytotoxicity by lymphocytes tended to decrease at high age, but impaired cytotoxity was also noted in young patients. A preliminary follow-up of patients 1-2 years after the beginning of treatment revealed almost abolished K-cell activity in four patients who died 6--13 months after testing. Patients in incomplete remission or with relapse after treatment had lower mean K-cell activity than those in complete remission. A similar, but less pronounced tendency was found for PHA-induced cytotoxicity. A prognostic role of impaired K-cell activity in Hodgkin's disease is suggested from these data, but requires confirmation in a larger clinical follow-up.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-1167571,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-4114496,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-4466607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-4542160,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-4543556,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-4549140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-4549627,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-4617353,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-6023376,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1081933-6035198
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0009-9104
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
376-83
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1081933-Adolescent,
pubmed-meshheading:1081933-Adult,
pubmed-meshheading:1081933-Age Factors,
pubmed-meshheading:1081933-Aged,
pubmed-meshheading:1081933-Antibodies,
pubmed-meshheading:1081933-B-Lymphocytes,
pubmed-meshheading:1081933-Cell Line,
pubmed-meshheading:1081933-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:1081933-DNA,
pubmed-meshheading:1081933-Follow-Up Studies,
pubmed-meshheading:1081933-Hodgkin Disease,
pubmed-meshheading:1081933-Humans,
pubmed-meshheading:1081933-Lectins,
pubmed-meshheading:1081933-Lymphocytes,
pubmed-meshheading:1081933-Middle Aged,
pubmed-meshheading:1081933-Prognosis,
pubmed-meshheading:1081933-T-Lymphocytes
|
pubmed:year |
1975
|
pubmed:articleTitle |
Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
|
pubmed:publicationType |
Journal Article
|